C
Abacus Global Management, Inc. ABX
$8.98 -$0.04-0.44% NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)

Company Overview

Abacus Global Management, Inc. is a publicly traded alternative asset manager that specializes in the life settlements industry, operating at the intersection of alternative investments, insurance-linked assets, and asset management. The company’s core business involves acquiring, managing, and financing portfolios of life insurance policies, which are held as long-duration alternative assets and offered to institutional investors. Its revenue is primarily derived from asset management fees, policy servicing income, and returns on retained policy interests.

The company traces its origins to the mid‑2000s as a privately held life settlements manager and gradually evolved into a vertically integrated platform combining origination, underwriting, servicing, and asset management. Abacus Global Management later became publicly listed to support capital formation, institutional expansion, and broader investor access. Its strategic positioning centers on scale, proprietary underwriting analytics, and end‑to‑end control of the life settlement value chain, which management positions as a differentiator relative to smaller brokers or single‑function competitors.

Business Operations

Abacus Global Management conducts operations primarily through its wholly owned subsidiary Abacus Life, Inc., which serves as the firm’s principal operating entity. The business is organized around integrated activities that include sourcing life insurance policies, actuarial and medical underwriting, portfolio construction, ongoing policy servicing, and asset management for institutional and third‑party capital. Revenue is generated through management fees, performance-linked income, servicing fees, and investment income on balance‑sheet policies.

Operations are predominantly U.S.-focused due to the regulatory structure of life insurance markets, with policy origination and servicing occurring across multiple states. The company controls proprietary underwriting technology, longevity modeling processes, and policy administration systems, which are used to evaluate risk and manage long-term cash flows. Based on publicly available disclosures, there are no material joint ventures reported; however, the firm maintains ongoing relationships with institutional investors, insurance carriers, and capital markets counterparties to support portfolio financing and distribution.

Strategic Position & Investments

Strategically, Abacus Global Management focuses on expanding assets under management by increasing policy acquisition volume, broadening institutional capital partnerships, and enhancing data-driven underwriting capabilities. Growth initiatives disclosed in public filings emphasize scaling managed funds, selectively retaining policy interests to capture long-term value, and improving operational efficiency through technology investment.

The company has pursued targeted acquisitions and internal investments to strengthen vertical integration and servicing capacity. Where disclosures reference acquired or internally developed platforms, management emphasizes risk management, regulatory compliance, and actuarial precision as core strategic priorities. Exposure to emerging sectors is primarily indirect, through the application of advanced analytics and medical data modeling rather than direct investment in unrelated technologies. Some details regarding specific acquisition economics and minority investments remain limited or are described at a high level in public sources; where granularity is lacking, data is inconclusive based on available public sources.

Geographic Footprint

Abacus Global Management is headquartered in the United States, with its principal executive offices and operational infrastructure located domestically. Its business footprint spans multiple U.S. states, reflecting the geographically dispersed nature of life insurance policy origination and servicing. Regulatory compliance and licensing requirements drive a state‑by‑state operational presence rather than centralized regional hubs.

International exposure is limited and indirect, primarily through institutional investors that may be domiciled outside the United States. There is no material evidence in public filings of significant non‑U.S. operating subsidiaries or direct foreign policy origination. As such, the company’s geographic influence is concentrated in North America, with global relevance arising mainly from cross‑border capital participation rather than operational deployment.

Leadership & Governance

Abacus Global Management is led by executives with long-standing experience in life settlements, asset management, and insurance-linked investments. The leadership team emphasizes disciplined underwriting, transparency, and long-term asset stewardship, consistent with the extended duration and regulatory sensitivity of life settlement portfolios. Governance practices are aligned with public company standards, with oversight provided by a board of directors and established committee structures.

Key executives disclosed in public filings include:

  • Jay JacksonChief Executive Officer
  • Martin FroehlichChief Investment Officer
  • Anthony D. RicciChief Financial Officer
  • Jonathan H. WarrenGeneral Counsel and Chief Compliance Officer

Public disclosures consistently describe leadership’s strategic vision as focused on scalable growth, institutional credibility, and risk-adjusted returns. Where executive roles or tenure differ slightly across filings and investor materials, the underlying leadership structure is substantially consistent; any minor discrepancies are not material based on available public sources.

Data complied by narrative technology. May contain errors

Top Tech Stocks
See All »
B
NVDA NASDAQ $172.70
B
AAPL NASDAQ $247.99
B
MSFT NASDAQ $381.87
Top Consumer Staple Stocks
See All »
B
WMT NASDAQ $119.02
B
Top Financial Stocks
See All »
B
B
JPM NYSE $286.56
B
V NYSE $301.62
Top Energy Stocks
See All »
B
ENB.TO TSX $73.47
B
ENB NYSE $53.46
Top Health Care Stocks
See All »
B
LLY NYSE $906.70
B
JNJ NYSE $235.37
B
AMGN NASDAQ $347.80
Top Real Estate Stocks
See All »
B
PLD NYSE $128.01